Grow Your Pharma Business Digitally
Weekly News Recap #Phispers
Stock Recap #PipelineProspector
Virtual Booth
Contact Supplier
Check COS databaseCheck USDMF database
Contact UsPharmaScopic.com
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Quadramet
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : National Cancer Institute | Jazz Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Radiolabeled Compounds
Upfront Cash : Inapplicable
June 25, 2013
Highest Development Status : Phase II
Stock Recap#PipelineProspector
Data Compilation#PharmaFlow